There has been enormous interest in the therapeutic use of stem cells for a diverse range of diseases (including diabetes, cancer, cardiovascular and musculoskeletal diseases and neurodegenerative disorders), because of their unique abilities to self- renew, proliferate and differentiate into specialized cells. To allow the potential of stem cells to be realized in the clinic, the unique ability of small molecules to direct and control stem cell fate has been increasingly harnessed, enabling controlled tissue repair and regeneration and meeting key challenges such as cell availability and allogenic rejection. In many laboratories scientists, are designing and delivering novel molecules to enable selective control of stem cell potentiation and differentiation, thereby gaining better understanding of the fundamental phenomena controlling stem cells and accelerating translation into a clinical context. At this symposium key scientists and stakeholders in the area will disclose recent progress in this field, identify new perspectives and discuss future challenges for the use of chemical approaches to facilitate stem cell therapy and regenerative medicine. We invite you to join this vibrant and timely event which will be held at the RSC Burlington House, London, W1J0BA.
Online registration is now open, via the Book Now link on this page. Please include the delegate name in the instruction and send a copy of the payment advice with the application form. The fees include attendance at the sessions, lunch and refreshments. The organisers are not registered for VAT and tax invoices cannot be issued.
Online registration is now open, via the Book Now link on this page. Please include the delegate name in the instruction and send a copy of the payment advice with the application form. The fees include attendance at the sessions, lunch and refreshments. The organisers are not registered for VAT and tax invoices cannot be issued.
